Olfactory functions at the intersection between environmental exposure to manganese and Parkinsonism

Journal of Trace Elements in Medicine and Biology

Volumn 26, Issue 2-3, 2012, Pages 179-182

  Zoni, Silvia ^a   Bonetti, Giulia ^a   Lucchini, Roberto ^a,b  

^a UNIVERSITY OF BRESCIA   (Italy)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Manganese; Olfaction; Parkinson's disease

Indexed keywords

ALCOHOL; DOPAMINE RECEPTOR; MANGANESE; METAL; ORGANIC SOLVENT;

ARTICLE; COGNITIVE DEFECT; DOPAMINERGIC SYSTEM; ENVIRONMENTAL EXPOSURE; GENETIC POLYMORPHISM; GERIATRIC PATIENT; HIGH RISK POPULATION; HUMAN; INTOXICATION; MANGANESE OVERLOAD; MOTOR COORDINATION; MOTOR DYSFUNCTION; NEUROLOGIC EXAMINATION; NEUROTOXICITY; OCCUPATIONAL EXPOSURE; OLFACTORY TRACT; PARKINSON DISEASE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY SYSTEM EXAMINATION; SMELLING; SMELLING DISORDER; TOXICOKINETICS; XENOBIOTIC METABOLISM;

ENVIRONMENTAL EXPOSURE; HUMANS; MANGANESE; OLFACTION DISORDERS; PARKINSONIAN DISORDERS;

EID: 84862556431     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2012.04.023     Document Type: Article

References (57)

1. Kandel E.R., Schwartz J., Jessell T.M. Principles of neural science 2000, McGraw-Hill Medical, New York. 4th ed.
2. Rombaux P., Collet S., Eloy P., Ledeghen S., Bertrand B. Smell disorders in ENT clinic. B-ENT 2005, (Suppl. 1):97-107.
3. Kern R.C. Chronic sinusitis and anosmia: pathologic changes in the olfactory mucosa. Laringoscope 2000, 110:1071-1077.
4. Callahan C.D., Hinkebein J.H. Assessment of anosmia after traumatic brain injury: performance of the characteristics of the University of Pennsylvania Smell Identification Test. J Head Trauma Rehabil 2002, 17:251-256.
5. Klimek L., Moll B., Amedee R.G., Mann W.J. Olfactory function after microscopic endonasal surgery in patients with polyps. Am J Rhinol 1997, 11:251-255.
6. Eibenstein A., Fioretti A.B., Lena C., Rosati N., Ottaviano L., Fusetti M. Olfactory screening test: experience in 102 Italian subjects. Acta Otorhinolaryngol Ital 2005, 25:18-22.
7. Ponsen M.M., Stoffers D., Twisk J.W., Wolters E.C., Berendse H.W. Hyposmia and executive dysfunction as predictors of future Parkinson's disease: a prospective study. Movement Disorders 2009, 24(7):1060-1065.
8. Sandmark B., Broms I., Lofgren L., Ohlson C.G. Olfactory function in painters exposed to organic solvents. Scand J Work Environ Health 1989, 15:60-63.
9. Sunderman F.W. Review: nasal toxicity, carcinogenicity and olfactory uptake of metals. Ann Clin Lab Sci 2001, 31(1):3-24.
10. Rupp C.I., Kurz M., Kemmler G., Mair D., Hausmann A., Hinterhuber H., et al. Reduced olfactory sensitivity, discrimination and identification in patients with alcohol dependence. Alcohol Clin Exp Res 2003, 27:432-439.
11. Gobba F. Olfactory toxicity: long-term effects of occupational exposures. Int Arch Occup Environ Health 2006, 79(4):322-331.
12. Wattendorf E., Welge-Lüssen A., Fiedler K., Bilecen D., Wolfensberger M., Fuhr P., et al. Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci 2009, 29(49):15410-15413.
13. Haehner A., Hummel T., Reichmann H. Olfactory dysfunction as a diagnostic marker for Parkinson's disease. Expert Rev Neurother 2009, 9(12):1773-1779.
14. Westermann B., Wattendorf E., Schwerdtfeger U., Husner A., Fuhr P., Gratzl O., et al. Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2008, 79(1):19-24.
15. Huisman E., Uylings H.B.M., Hoogland P.V. Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson's disease patients. Movement Disorders 2008, 23:1407-1413.
16. Liberini P., Parola S., Spano P.F., Antonini L. Olfaction in Parkinson's disease: methods of assessment and clinical relevance. J Neurol 2000, 247:88-96.
17. Huisman E., Uylings H.B.M., Hoogland P.V. A 100% increase of dopaminergic cells in the olfactory bulb may explain hyposmia in Parkinson's disease. Movement Disorders 2004, 19(6):687-692.
18. Herting B., Schulze S., Reichmann H., Haehner A., Hummel T. A longitudinal study of olfactory function in patients with idiopathic Parkinson's disease. J Neurol 2008, 255(3):367-370.
19. Lucchini R.G., Dorman D.C., Elder A., Veronesi B. Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology 2012, 001. 10.1016/j.neuro.2011.12.
20. Elder A., Gelein R., Silva V., Feikert T., Opanashuk L., Carter J., et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect 2006, 114:1172-1178.
21. Sjogren B., Iregren A., Frech W., Hagman M., Johansson L., Tesarz M., et al. Effects on the nervous system among welders exposed to aluminum and manganese. Occup Environ Med 1996, 53:32-40.
22. Kim K.S., Kim Y., Jin Y., Kim E., Yang J.S., Kwon K.-R., et al. Factors associated with psychoneurobehavioral outcomes in workers exposed to manganese. Korean J Occup Environ Med 1999, 11:213-228.
23. Moon D.-H, Son B.-C., Kang D.-M. Manganese exposure and its health hazards of welders. Korean J Occup Environ Med 1999, 11:476-491.
24. Kim E., Kim Y., Cheong H.K., Cho S., Shin Y.C., Sakong J., et al. Pallidal index on MRI as a target organ dose of manganese: structural equation analysis. Neurotoxicology 2005, 26:351-359.
25. Yuan H., He S., He M., Niu Q., Wang L., Wang S. A comprehensive study on neurobehavior, neurotransmitters and lymphocyte subsets alteration of Chinese manganese welding workers. Life Sci 2006, 78:1324-1328.
26. Bowler R.M., Roels H.A., Nakagawa S., Drezgic M., Diamond E., Park R., et al. Dose-effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders. Occup Environ Med 2007, 64:167-177.
27. Ellingsen D.G., Konstantinov R., Bast-Pettersen R., Merkurjeva L., Chashchin M., Thomassen Y., et al. A neurobehavioral study of current and former welders exposed to manganese. Neurotoxicology 2008, 29:48-59.
28. Roels H., Lauwerys R., Buchet J.P., Genet P., Sarhan M.J., Hanotiau I., et al. Epidemiological survey among workers exposed to manganese: effects on lung, central nervous system, and some biological indices. Am J Ind Med 1987, 11:307-327.
29. Roels H., Lauwerys R., Buchet J.P., Genet P., Sarhan M.J., Hanotiau I., et al. Erratum Am J Ind Med 1987, 12:119-120.
30. Roels H.A., Ghyselen P., Buchet J.P., Ceulemans E., Lauwerys R.R. Assessment of the permissible exposure level to manganese in workers exposed to manganese dioxide dust. Br J Ind Med 1992, 49:25-34.
31. Lucchini R., Sellis L., Folli D., Apostoli P., Mutti A., Vanoni O., et al. Neurobehavioral effects of manganese in workers from a ferroalloy plant after temporary cessation of exposure. Scand J Work Environ Health 1995, 21:143-149.
32. Lucchini R., Bergamaschi E., Smargiassi A., Festa D., Apostoli P. Motor function olfactory threshold, and hematological indices in manganese-exposed ferroalloy workers. Environ Res 1997, 73:175-180.
33. Lucchini R., Apostoli P., Pierrone C., Placida D., Albini E., Migliorati P., et al. Long term exposure to low levels of manganese oxides and neurofunctional changes in ferroalloy workers. Neurotoxicology 1999, 20:287-298.
34. Chia S.E., Foo S.C., Gan S.L., Jeyaratnam J., Tian C.S. Neurobehavioral functions among workers exposed to manganese ore. Scand J work Environ Health 1993, 19:264-270.
35. Chia S.E., Gan S.L., Chua L.H., Foo S.C., Jeyaratnam J. Postural stability among manganese exposed workers. Neurotoxicology 1995, 16:519-526.
36. Levy B.S., Nassetta W.J. Neurologic effects of manganese in humans: a review. Int J Occup Environ Health 2003, 9:153-163.
37. Kim Y., Jeong K.S., Song H.J., Lee J.J., Seo J.H., Kim G.C., et al. Altered white matter microstructural integrity revealed by voxel-wise analysis of diffusion tensor imaging in welders with manganese exposure. Neurotoxicology 2011, 32(1):100-109.
38. Wasserman G.A., Liu X., Parvez F., Ahsan H., Levy D., Factor-Litvak P., et al. Water manganese exposure and children's intellectual function in Araihazar Bangladesh. Environ Health Perspect 2006, 114(1):124-129.
39. Wright R.O., Amarasiriwardena C., Woolf A.D., Jim R., Bellinger D.C. Neuropsychological correlates of hair arsenic, manganese, and cadmium levels in school-age children residing near a hazardous waste site. Neurotoxicology 2006, 27(2):210-216.
40. Riojas-Rodriguez H., Solis-Vivanco R., Schilmann A., Montes S., Rodriguez S., Rios C., et al. Intellectual function in Mexican children living in a mining area and environmentally exposed to manganese. Environ Health Perspect 2010, 118(10):1465-1470.
41. Bouchard M.F., Sauve S., Barbeau B., Legrand M., Brodeur M.E., Bouffard T., et al. Intellectual impairment in school-age children exposed to manganese from drinking water. Environ Health Perspect 2011, 119(1):138-143.
42. Menezes-Filho J.A., Novaes Cde O., Moreira J.C., Sarcinelli P.N., Mergler D. Elevated manganese and cognitive performance in school-aged children and their mothers. Environ Res 2011, 111(1):156-163.
43. Takser L., Mergler D., Hellier G., Sahuquillo J., Huel G. Manganese, monoamine metabolite levels at birth, and child psychomotor development. Neurotoxicology 2003, 24(4-5):667-674.
44. Huang E., Ong W.Y., Connor J.R. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 2004, 128(3):487-496.
45. Salazar J., Mena N., Hunot S., Prigent A., Alvarez-Fischer D., Arredondo M., et al. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc Natl Acad Sci USA 2008, 105(47):18578-18583.
46. He Q., Du T., Yu X., Xie A., Song N., Kang Q., et al. DMT1 polymorphism and risk of Parkinson's disease. Neurosci Lett 2011, 501(3):128-131.
47. Sriram K., Lin G.X., Jefferson A.M., Roberts J.R., Chapman R.S., Chen B.T., et al. Dopaminergic neurotoxicity following pulmonary exposure to manganese-containing welding fumes. Arch Toxicol 2010, 84(7):521-540.
48. Benedetto A., Au C., Avila D.S., Milatovic D., Aschner M. Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans. PLoS Genet 2010, 6(8).
49. Thompson K., Molina R.M., Donaghey T., Schwob J.E., Brain J.D., Wessling-Resnick M. Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J 2007, 21:223-230.
50. Marreilha Dos Santos A.P., Lopes Santos M., Batoréu M.C., Aschner M. Prolactin is a peripheral marker of manganese neurotoxicity. Brain Res 2011 Mar 25, 1382:282-290.
51. Montes S., Schilmann A., Riojas-Rodriguez H., Rodriguez-Agudelo Y., Solis-Vivanco R., Rodriguez-Dozal S.L., et al. Serum prolactin rises in Mexican school children exposed to airborne manganese. Environ Res 2011, 111(8):1302-1308.
52. Health Canada. Human Health Risk Assessment for Inhaled Manganese. 2010; ISBN: 978-1-100-15221-9, Cat. No.: H128-1/10-600E, HC Pub.: 100122.
53. Lucchini R.G., Albini E., Benedetti L., Borghesi S., Coccaglio R., Malara E., et al. High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am J Ind Med 2007, 50(11):788-800.
54. Lucchini R.G., Guazzetti S., Zoni S., Donna F., Peter S.A., Zacco A., et al. Tremor, olfactory and motor changes in Italian adolescents exposed to historical ferro-manganese emission. Neurotoxicology 2012, 10.1016/j.neuro.2012.01.00.
55. Rentschler G., Covolo L., Ahmadi Haddad A., Lucchini R.G., Zoni S., Broberg K. ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese. Neurotoxicology 2012, 10.1016/j.neuro.2012.01.007.
56. Rosenbaum J.N., Duggan A., García-Añoveros J. Insm1 promotes the transition of olfactory progenitors from apical and proliferative to basal, terminally dividing and neuronogenic. Neural Dev 2011, 6:6.
57. Duggan A., Madathany T., de Castro S.C., Gerrelli D., Guddati K., Garcia-Anoveros J. Transient expression of the conserved zinc finger gene INSM1 in progenitors and nascent neurons throughout embryonic and adult neurogenesis. J Comp Neurol 2008, 507:1497-1520.